- Home
- EXEL vs JBHT Comparison
EXEL vs JBHT Comparison
Compare EXEL & JBHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- JBHT
- Stock Information
- Founded
- EXEL 1994
- JBHT 1961
- Country
- EXEL United States
- JBHT United States
- Employees
- EXEL 1147
- JBHT N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- JBHT Trucking Freight/Courier Services
- Sector
- EXEL Health Care
- JBHT Industrials
- Exchange
- EXEL Nasdaq
- JBHT Nasdaq
- Market Cap
- EXEL 10.4B
- JBHT 14.4B
- IPO Year
- EXEL 2000
- JBHT N/A
- Fundamental
- Price
- EXEL $38.31
- JBHT $143.45
- Analyst Decision
- EXEL Buy
- JBHT Buy
- Analyst Count
- EXEL 21
- JBHT 19
- Target Price
- EXEL $43.65
- JBHT $168.58
- AVG Volume (30 Days)
- EXEL 4.0M
- JBHT 1.0M
- Earning Date
- EXEL 07-28-2025
- JBHT 07-15-2025
- Dividend Yield
- EXEL N/A
- JBHT 1.23%
- EPS Growth
- EXEL 81.76
- JBHT N/A
- EPS
- EXEL 2.08
- JBHT 5.51
- Revenue
- EXEL $2,230,005,000.00
- JBHT $12,064,092,000.00
- Revenue This Year
- EXEL $9.88
- JBHT $1.38
- Revenue Next Year
- EXEL $12.59
- JBHT $5.32
- P/E Ratio
- EXEL $18.45
- JBHT $26.03
- Revenue Growth
- EXEL 10.73
- JBHT N/A
- 52 Week Low
- EXEL $25.12
- JBHT $122.79
- 52 Week High
- EXEL $49.62
- JBHT $200.40
- Technical
- Relative Strength Index (RSI)
- EXEL 41.08
- JBHT 47.68
- Support Level
- EXEL $37.01
- JBHT $142.17
- Resistance Level
- EXEL $38.78
- JBHT $146.07
- Average True Range (ATR)
- EXEL 1.12
- JBHT 3.34
- MACD
- EXEL 0.07
- JBHT 0.01
- Stochastic Oscillator
- EXEL 83.79
- JBHT 53.34
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About JBHT J.B. Hunt Transport Services Inc.
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales), dedicated trucking services that provide customer-specific fleet needs (27%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (12%).